Atlas Trials

XW004 To Evaluate the Safety, Tolerability, PK, and PD of Oral Ecnoglutide Tablet in Healthy Adults

Clinical trial NCT05184322 · COMPLETED

Trial details

NCT number
NCT05184322
Sponsor
Sciwind Biosciences APAC CO Pty. Ltd.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
ObesityType 2 Diabetes Mellitus
Start date
2022-04-12
Primary completion
2024-07-13
Enrollment
87

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.